JPRN-UMIN000037232
Recruiting
未知
The continuous evaluation of EGFR mutation in EGFR-mutation positive lung cancer patients during EGFR TKI treatment - The continuous evaluation of EGFR mutation during EGFR TKI treatment
Advanced Cancer Translational Research Institute0 sites100 target enrollmentJuly 4, 2019
Conditionsnon-small cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- non-small cell lung cancer
- Sponsor
- Advanced Cancer Translational Research Institute
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •disagreed patients and patients carrying HBV or HCV
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective observational study of EGFR mutation allele frequency using Cell free DNAJPRN-UMIN000036149Hamamatsu University School of Medicine33
Completed
Not Applicable
An observational study of EGFR mutation status by circulating tumor DNA during the osimertinib treatment of lung cancer harboring EGFR activating and T790M mutations.lung CancerJPRN-UMIN000025278Miyagi Cancer Center60
Completed
Not Applicable
An obsevational study of EGFR mutation status by circulating tumor DNA and tissue during the osimertinib treatment in poor PS patients with T790M positive advanced NSCLCnon small cell lung cancerJPRN-UMIN000025718orth East Japan Study Group (NEJSG)32
Completed
Not Applicable
The analysis of significance of EGFR mutations in lung non-adeno and non small cell carcinoma; retrospective multicenter studyEGFR mutations in lung non-adeno and non small cell carcinomaJPRN-UMIN000007294ung Oncology Group in Kyushu, Japan (LOGIK)100
Completed
Not Applicable
Study on the detection of EGFR mutation using the high sensitive PCR method in lung cancerJPRN-UMIN000033567Shizuoka Cancer Center50